Imprinting effect in premature ovarian failure confined to paternally inherited fragile X premutations

American Journal of Human Genetics

Volumn 66, Issue 2, 2000, Pages 413-418

  Hundscheid, Rubin D L ^a   Sistermans, Erik A ^a   Thomas, Chris M G ^a   Braat, Didi D M ^a   Straatman, Huub ^a   Kiemeney, Lambertus A L M ^a   Oostra, Ben A ^b   Smits, Arie P T ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; FEMALE; FEMALE FERTILITY; FRAGILE X SYNDROME; GENE MUTATION; GENETIC RISK; GENOME IMPRINTING; HERITABILITY; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; MENSTRUAL CYCLE; OVARY DISEASE; PRIORITY JOURNAL;

FALLOPIA; MARTES PENNANTI;

EID: 0033912299     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/302774     Document Type: Article

References (28)

1. Allingham-Hawkins DJ, Babul-Hirji R, Chitayat D, Holden JJ, Yang KT, Lee C, Hudson R, et al (1999) Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study - preliminary data. Am J Med Genet 83:322-325
2. Bächner D, Manca A, Steinbach P, Wöhrle D, Just W, Vogel W, Hameister H, et al (1993) Enhanced expression of the murine FMR1 gene during germ cell proliferation suggests a special function in both the male and the female gonad. Hum Mol Genet 2:2043-2050
3. Conway GS, Payne NN, Webb J, Murray A, Jacobs PA (1998) Fragile X premutation screening in women with premature ovarian failure. Hum Reprod 13:1184-1187
4. Cooper DW (1971) Directed genetic change model for X chromosome inactivation in eutherian mammals. Nature 230: 292-294
5. Coulam CB, Adamson SC, Annegers JF (1986) Incidence of premature ovarian failure. Obstet Gynecol 67:604-606
6. Dorland M, van Kooij RJ, te Velde ER (1998) General aging and ovarian aging. Maturitas 30:113-118
7. Dutch-Belgian Fragile X Consortium (1994) Fmr1 knockout mice: a model to study fragile X mental retardation. Cell 78:23-33
8. Eichenlaub-Ritter U (1998) Genetics of oocyte ageing. Maturitas 30:143-169
9. Epstein CJ, Smith S, Travis B, Tucker G (1978) Both X chromosomes function before visible X-chromosome inactivation in female mouse embryos. Nature 274:500-503
10. Faddy MJ, Gosden RG (1996) A model confirming the decline in follicle numbers to the age of menopause in women. Hum Reprod 11:1484-1486
11. Feng Y, Lakkis L, Devys D, Warren ST (1995) Quantitative comparison of FMR1 gene expression in normal and premutation alleles. Am J Hum Genet 56:106-113
12. Ginsburg J (1991) What determines the age at the menopause? the number of ovarian follicles seems to be the most important factor. Br Med J 302:1288-1289
13. Gosden RG, Faddy MJ (1998) Biological bases of premature ovarian failure. Reprod Fertil Dev 10:73-78
14. Imbert G, Feng Y, Nelson DL, Warren ST, Mandel JL (1998) FMR1 and mutations in fragile syndrome: molecular biology, biochemistry, and genetics. In: Wells RD, Warren ST (eds) Genetic instabilities and hereditary neurological disorders. Academic Press, New York, pp 27-53
15. Kenneson A, Cramer DW, Warren ST (1997) Fragile X premutations are not a major cause of early menopause. Am J Hum Genet 61:1362-1369
16. Malter HE, Iber JC, Willemsen R, de Graaff E, Tarleton JC, Leisti J, Warren ST, Oostra BA (1997) Characterization of the full fragile X syndrome mutation in fetal gametes. Nat Genet 15:165-169
17. Monesi V, Geremia R, D'Agostino A, Boitani C (1978) Biochemistry of male germ cell differentiation in mammals: RNA synthesis in meiotic and postmeiotic cells. Curr Top Dev Biol 12:11-36
18. Murray A, Webb J, Grimley S, Conway G, Jacobs P (1998) Studies of FRAXA and FRAXE in women with premature ovarian failure. J Med Genet 35:637-640
19. Partington MW, Moore DY, Turner GM (1996) Confirmation of early menopause in fragile X carriers. Am J Med Genet 64:370-372
20. Schwartz CE, Dean J, Howard-Peebles PN, Bugge M, Mikkelsen M, Tommerup N, Hull C, et al (1994) Obstetrical and gynecological complications in fragile X carriers: a multicenter study. Am J Med Genet 51:400-402
21. Skuse DH, James RS, Bishop DV, Coppin B, Dalton P, Aamodt-Leeper G, Bacarese-Hamilton M, et al (1997) Evidence from Turner's syndrome of an imprinted X-linked locus affecting cognitive function. Nature 387:705-708
22. Tamanini F, Willemsen R, van Unen L, Bontekoe C, Galjaard H, Oostra BA, Hoogeveen AT (1997) Differential expression of FMR1, FXR1 and FXR2 proteins in human brain and testis. Hum Mol Genet 6:1315-1322
23. Thomas CM, Corbey RS, Rolland R (1977) Assessment of unconjugated oestradiol and progesterone serum levels throughout pregnancy in normal women and in women with hyperprolactinaemia, who conceived after bromocriptine treatment. Acta Endocrinol (Copenh) 86:405-414
24. Uzielli ML, Guarducci S, Lapi E, Cecconi A, Ricci U, Ricotti G, Biondi C, et al. (1999) Premature ovarian failure (POF) and fragile X premutation females: from POF to fragile X carrier identification, from fragile X carrier diagnosis to POF association data. Am J Med Genet 84:300-303
25. van Kasteren YM, Hundscheid RD, Smits AP, Cremers FP, van Zonneveld P, Braat DD (1999) Familial idiopathic premature ovarian failure: an overrated and underestimated genetic disease? Hum Reprod 14:2455-2459
26. Verkerk AJMH, Pieretti M, Sutcliffe JS, Fu YH, Kuhl DPA, Pizutti A, Reiner O, et al (1991) Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65:905-914
27. West JD, Frels WI, Chapman VM, Papaioannou VE (1977) Preferential expression of the maternally derived X chromosome in the mouse yolk sac. Cell 12:873-882
28. Willemsen R, Oosterwijk JC, Los FJ, Galjaard H, Oostra BA (1996) Prenatal diagnosis of fragile X syndrome. Lancet 348:967-968